Beijing Gingko-Group Biological Technology Co., Ltd.

Location not on file

OncologymRNAPhase I

Compare Sign in to watch

What changed

NIH R01 · $0.7M · A platform for scalable spatial single cell genomics

2mo agoGrant renewalMay 14, 2026Source filing (opens the source filing in a new tab)

Momentum

95no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

813 pre-ticker oncology companies at Phase I

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
NA registered
Dec 30, 2025
Cardiovascular Diseases, Stroke, Cerebrovascular Disorders · RECRUITING · sponsor: I-Shou University · Hybrid Stroke Rehab With Mirror Priming
ClinicalTrials.gov · NCT07324278 (opens the source filing in a new tab)
Trial
NA registered
Jul 15, 2025
Diabetes Mellitus, Type 2 Diabetes · RECRUITING · sponsor: Sun Yat-sen University · Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm
ClinicalTrials.gov · NCT07066891 (opens the source filing in a new tab)
Grant
R16 · $147k · non-dilutive
Jul 1, 2025
CALIFORNIA STATE UNIV SAN BERNARDINO · PI LI, YAWEN · NIGMS · award ends Apr 30, 2029 · Measuring Dynamic Capability of Adult Day Health Services in the US
NIH RePORTER · NIH RePORTER 11097470 (opens the source filing in a new tab)
Grant
R35 · $356k · non-dilutive
May 15, 2025
DUKE UNIVERSITY · PI YANG, WEITAO · NIGMS · award ends Feb 28, 2030 · Computer Simulations of Enzymes
NIH RePORTER · NIH RePORTER 11090802 (opens the source filing in a new tab)
Grant
R01 · $752k · non-dilutive
May 6, 2025
SLOAN-KETTERING INST CAN RESEARCH · PI BERNSTEIN, JONINE L. · NCI · award ends Apr 30, 2030 · The Genetic Epidemiology of Radiation-Associated Contralateral Breast Cancer
NIH RePORTER · NIH RePORTER 11050395 (opens the source filing in a new tab)
Grant
U01 · $3.1M · non-dilutive
May 1, 2025
DUKE UNIVERSITY · PI HUANG, Z JOSH · NIMH · award ends Feb 28, 2030 · RNA Programmable and Scalable Brain Cell Type Tools Across Vertebrates
NIH RePORTER · NIH RePORTER 11116509 (opens the source filing in a new tab)
Grant
U01 · $2.6M · non-dilutive
May 1, 2025
DUKE UNIVERSITY · PI HUANG, Z JOSH · NIMH · award ends Feb 28, 2030 · RNA Programmable and Scalable Brain Cell Type Tools Across Vertebrates
NIH RePORTER · NIH RePORTER 11326657 (opens the source filing in a new tab)
Trial
EARLY_PHASE1 registered
Jan 27, 2025
Relapsed/ Refractory Multiple Myeloma · RECRUITING · sponsor: Chunrui Li · A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma
ClinicalTrials.gov · NCT06791681 (opens the source filing in a new tab)
Patent
Patent granted
Jan 7, 2025
assignee: Beijing Gingko-Group Biological Technology Co., Ltd. · PROCESSES FOR TRANSGLUCOSYLATION OF STEVIOL GLYCOSIDES
USPTO · US 12185743 (opens the source filing in a new tab)
Grant
R01 · $755k · non-dilutive
Sep 30, 2024
JOHNS HOPKINS UNIVERSITY · PI ARKING, DAN E · NIA · award ends May 31, 2028 · Circulating and Brain Lipidomics, Cognition and Dementia
NIH RePORTER · NIH RePORTER 11193793 (opens the source filing in a new tab)
Grant
R21 · $188k · non-dilutive
Sep 15, 2024
UNIVERSITY OF WISCONSIN-MADISON · PI HUANG, ZHEN · NIA · award ends May 31, 2027 · A Mouse Model for Braak I/II Alzheimer's Pathology
NIH RePORTER · NIH RePORTER 11184213 (opens the source filing in a new tab)
Trial
Study registered
Sep 11, 2024
Arthritis, Polymyalgia Rheumatica, Immune Checkpoint Inhibitors · RECRUITING · sponsor: M.D. Anderson Cancer Center · A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
ClinicalTrials.gov · NCT06647134 (opens the source filing in a new tab)
Grant
R01 · $493k · non-dilutive
Aug 15, 2024
RHODE ISLAND HOSPITAL · PI YANG, WENTIAN · NIDDK · award ends May 31, 2027 · SHP2's Regulation of the Bone Marrow Stroma and Hematopoietic Crosstalk
NIH RePORTER · NIH RePORTER 11168685 (opens the source filing in a new tab)
Grant
R21 · $211k · non-dilutive
Aug 15, 2024
UNIVERSITY OF CALIFORNIA AT DAVIS · PI YANG, WEIJIAN · NIBIB · award ends Jun 30, 2027 · Simultaneous two-photon imaging and two-photon manipulation of neural activity in freely behaving mice
NIH RePORTER · NIH RePORTER 11167736 (opens the source filing in a new tab)
Grant
R01 · $491k · non-dilutive
Aug 12, 2024
VIRGINIA COMMONWEALTH UNIVERSITY · PI LI, CHUNHAO CHRIS · NIDCR · award ends Jun 30, 2029 · Decoding the glycome of oral Treponema denticola
NIH RePORTER · NIH RePORTER 11167825 (opens the source filing in a new tab)
Grant
K01 · $156k · non-dilutive
Aug 1, 2024
MASSACHUSETTS GENERAL HOSPITAL · PI LI, YONGLI · NIDDK · award ends May 31, 2029 · Diagnosis, Treatment, and Monitoring of Polymicrobial Infections in Diabetic Wounds
NIH RePORTER · NIH RePORTER 11145815 (opens the source filing in a new tab)
Grant
R01 · $469k · non-dilutive
Aug 1, 2024
YALE UNIVERSITY · PI LI, CHIANG-SHAN RAY · NIDA · award ends Jun 30, 2029 · Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse: An RCT of CBT for Insomnia in Adults who Smoke
NIH RePORTER · NIH RePORTER 11141173 (opens the source filing in a new tab)
Grant
R35 · $403k · non-dilutive
Jul 19, 2024
UNIVERSITY OF CHICAGO · PI LI, YANG · NIGMS · award ends May 31, 2029 · Computational genomics approaches to study mechanisms and function of mRNA splicing
NIH RePORTER · NIH RePORTER 11141693 (opens the source filing in a new tab)
Grant
R01 · $688k · non-dilutive
May 20, 2024
UT SOUTHWESTERN MEDICAL CENTER · PI LI, CHANGWEI · NIDDK · award ends Jan 31, 2029 · The quality and quantity of mitochondrial DNA in chronic kidney disease progression
NIH RePORTER · NIH RePORTER 11231207 (opens the source filing in a new tab)
Grant
R01 · $463k · non-dilutive
Aug 18, 2022
STATE UNIVERSITY NEW YORK STONY BROOK · PI YANG, WEI · NCI · award ends May 31, 2028 · RIPK2/MKK7/c-Myc Signaling as a Therapeutic Target in Prostate Cancer Metastasis
NIH RePORTER · NIH RePORTER 10896995 (opens the source filing in a new tab)
Grant
R01 · $535k · non-dilutive
Aug 10, 2022
GEORGETOWN UNIVERSITY · PI WALDMAN, TODD A · NCI · award ends Jul 31, 2027 · STAG2 mutations and 3D genome organization in glioblastoma multiforme
NIH RePORTER · NIH RePORTER 11146340 (opens the source filing in a new tab)
Grant
R01 · $627k · non-dilutive
Aug 1, 2022
UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LI, CHUN · NCI · award ends Jun 30, 2027 · Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
NIH RePORTER · NIH RePORTER 11124644 (opens the source filing in a new tab)
Grant
R01 · $610k · non-dilutive
Jul 2, 2022
UNIVERSITY OF ILLINOIS AT CHICAGO · PI KELLY, TANIKA NICOLE · NIDDK · award ends Mar 31, 2027 · Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients
NIH RePORTER · NIH RePORTER 11113942 (opens the source filing in a new tab)
Grant
R01 · $594k · non-dilutive
Jul 1, 2022
CASE WESTERN RESERVE UNIVERSITY · PI LI, YAN · NIDDK · award ends Jun 30, 2027 · Understanding the variation of induced β-cell differentiation.
NIH RePORTER · NIH RePORTER 11093969 (opens the source filing in a new tab)
Grant
R01 · $475k · non-dilutive
May 1, 2022
UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRANCESCHINI, NORA · NHLBI · award ends Apr 30, 2026 · Genetics of Cardiovascular Disease in Chronic Kidney Disease
NIH RePORTER · NIH RePORTER 11077309 (opens the source filing in a new tab)
Grant
DP1 · $1.1M · non-dilutive
Sep 7, 2021
DUKE UNIVERSITY · PI HUANG, Z JOSH · NIMH · award ends Jun 30, 2026 · RNA-programmable cell-type targeting, editing, and therapy
NIH RePORTER · NIH RePORTER 11117065 (opens the source filing in a new tab)
Grant
U01 · $948k · non-dilutive
Jun 8, 2021
UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, YUN · NHGRI · award ends Mar 31, 2027 · Polygenic risk scores for cardiometabolic disorders: the role of blood cells immune response and evolutionary adaptation
NIH RePORTER · NIH RePORTER 11061790 (opens the source filing in a new tab)
Grant
P30 · $463k · non-dilutive
Apr 15, 2020
JOHNS HOPKINS UNIVERSITY · PI TRONCOSO, JUAN · NIA · award ends Mar 31, 2030 · Core D: Neuropathology Core
NIH RePORTER · NIH RePORTER 11114236 (opens the source filing in a new tab)
Grant
R01 · $795k · non-dilutive
Feb 1, 2020
UNIVERSITY OF WASHINGTON · PI REINER, ALEXANDER P · NHLBI · award ends Apr 30, 2028 · Next generation functional genomics of hematology traits
NIH RePORTER · NIH RePORTER 11134527 (opens the source filing in a new tab)
Trial
Study registered
Dec 30, 2019
Hypertension, Blood Pressure · SUSPENDED · sponsor: Yan Li · A Prospective Study on The"Management of Hypertension in Young and Middle-aged Subjects in Enterprises Setting"
ClinicalTrials.gov · NCT04135911 (opens the source filing in a new tab)
Grant
R01 · $682k · non-dilutive
Aug 8, 2019
BROAD INSTITUTE, INC. · PI CHEN, FEI · NHGRI · award ends Apr 30, 2028 · A platform for scalable spatial single cell genomics
NIH RePORTER · NIH RePORTER 11332923 (opens the source filing in a new tab)
Grant
R01 · $598k · non-dilutive
Jul 1, 2018
CASE WESTERN RESERVE UNIVERSITY · PI LI, YAN · NIDDK · award ends Jun 30, 2028 · Comprehensive characterization of HNF1A-driven beta-cell heterogeneity
NIH RePORTER · NIH RePORTER 11123504 (opens the source filing in a new tab)
Grant
R01 · $548k · non-dilutive
Aug 3, 2017
CASE WESTERN RESERVE UNIVERSITY · PI JIN, FULAI · NHGRI · award ends May 31, 2027 · Robust mapping of chromatin loops from sparse or single cell Hi-C data with DeepLoop
NIH RePORTER · NIH RePORTER 11099807 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75principal investigator HUANG, Z JOSH is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75principal investigator HUANG, ZHEN is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75principal investigator YANG, WEITAO is named on this company's filings
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the patent record at 0.28no candidate cleared the review threshold

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.7M · A platform for scalable spatial single cell genomics
2mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
3mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
3mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH U01 · $2.6M · RNA Programmable and Scalable Brain Cell Type Tools Across Vertebrates
3mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Hybrid Stroke Rehab With Mirror Priming
6mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Hybrid Stroke Rehab With Mirror Priming
6mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm
11mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm
11mo agoTrial recruitingSource (opens the source filing in a new tab)
NIH DP1 · $1.1M · RNA-programmable cell-type targeting, editing, and therapy
12mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Pre-IND Development of Polymeric Micelles with Dual Drug Payloads for HCC Therapy
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R21 · $0.2M · Simultaneous two-photon imaging and two-photon manipulation of neural activity in freely behaving mice
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Understanding the variation of induced β-cell differentiation.
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R16 · $0.1M · Measuring Dynamic Capability of Adult Day Health Services in the US
Jun 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Comprehensive characterization of HNF1A-driven beta-cell heterogeneity
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Robust mapping of chromatin loops from sparse or single cell Hi-C data with DeepLoop
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · SHP2's Regulation of the Bone Marrow Stroma and Hematopoietic Crosstalk
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Next generation functional genomics of hematology traits
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse: An RCT of CBT for Insomnia in Adults who Smoke
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · STAG2 mutations and 3D genome organization in glioblastoma multiforme
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.5M · Core D: Neuropathology Core
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH K01 · $0.2M · Diagnosis, Treatment, and Monitoring of Polymicrobial Infections in Diabetic Wounds
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH U01 · $0.9M · Polygenic risk scores for cardiometabolic disorders: the role of blood cells immune response and evolutionary adaptation
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Decoding the glycome of oral Treponema denticola
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R35 · $0.4M · Computer Simulations of Enzymes
May 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Circulating and Brain Lipidomics, Cognition and Dementia
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · The Genetic Epidemiology of Radiation-Associated Contralateral Breast Cancer
May 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.5M · RIPK2/MKK7/c-Myc Signaling as a Therapeutic Target in Prostate Cancer Metastasis
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.5M · Genetics of Cardiovascular Disease in Chronic Kidney Disease
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · The quality and quantity of mitochondrial DNA in chronic kidney disease progression
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH R35 · $0.4M · Computational genomics approaches to study mechanisms and function of mRNA splicing
May 2025Grant renewalSource (opens the source filing in a new tab)
NIH U01 · $3.1M · RNA Programmable and Scalable Brain Cell Type Tools Across Vertebrates
May 2025New grantSource (opens the source filing in a new tab)
NIH R21 · $0.2M · A Mouse Model for Braak I/II Alzheimer's Pathology
Apr 2025Grant renewalSource (opens the source filing in a new tab)
Phase I trial registered: A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma
Feb 2025Trial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: A Prospective Study on The"Management of Hypertension in Young and Middle-aged Subjects in Enterprises Setting"
Jan 2025Trial registeredSource (opens the source filing in a new tab)
Patent granted · PROCESSES FOR TRANSGLUCOSYLATION OF STEVIOL GLYCOSIDES
Jan 2025Patent grantedSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

NA registered

NA registered

R16 · $147k · non-dilutive

R35 · $356k · non-dilutive

R01 · $752k · non-dilutive

U01 · $3.1M · non-dilutive

U01 · $2.6M · non-dilutive

EARLY_PHASE1 registered

Patent granted

R01 · $755k · non-dilutive

R21 · $188k · non-dilutive

Study registered

R01 · $493k · non-dilutive

R21 · $211k · non-dilutive

R01 · $491k · non-dilutive

K01 · $156k · non-dilutive

R01 · $469k · non-dilutive

R35 · $403k · non-dilutive

R01 · $688k · non-dilutive

R01 · $463k · non-dilutive

R01 · $535k · non-dilutive

R01 · $627k · non-dilutive

R01 · $610k · non-dilutive

R01 · $594k · non-dilutive

R01 · $475k · non-dilutive

DP1 · $1.1M · non-dilutive

U01 · $948k · non-dilutive

P30 · $463k · non-dilutive

R01 · $795k · non-dilutive

Study registered

R01 · $682k · non-dilutive

R01 · $598k · non-dilutive

R01 · $548k · non-dilutive